Total Payments
$252,515
2024 Payments
$2,037
Companies
26
Transactions
572
Medicare Patients
9,283
Medicare Billing
$1.7M
Payment Breakdown by Category
Other$199,077 (78.8%)
Travel$28,983 (11.5%)
Food & Beverage$15,298 (6.1%)
Consulting$9,146 (3.6%)
Education$10.12 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $199,077 | 41 | 78.8% |
| Travel and Lodging | $28,983 | 85 | 11.5% |
| Food and Beverage | $15,298 | 441 | 6.1% |
| Consulting Fee | $9,146 | 3 | 3.6% |
| Education | $10.12 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $243,121 | 303 | $0 (2020) |
| Boston Scientific Corporation | $2,740 | 113 | $0 (2024) |
| Nevro Corp. | $1,508 | 53 | $0 (2024) |
| Stryker Corporation | $1,315 | 7 | $0 (2024) |
| Relievant Medsystems, Inc. | $1,275 | 12 | $0 (2023) |
| Medtronic, Inc. | $704.69 | 14 | $0 (2022) |
| ABBVIE INC. | $393.55 | 20 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $267.28 | 13 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $204.80 | 6 | $0 (2022) |
| Nutech Spine, Inc. | $202.86 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,037 | 55 | Stryker Corporation ($1,315) |
| 2023 | $2,605 | 76 | Relievant Medsystems, Inc. ($1,275) |
| 2022 | $1,338 | 77 | BOSTON SCIENTIFIC CORPORATION ($384.53) |
| 2021 | $1,404 | 30 | Nevro Corp. ($604.22) |
| 2020 | $1,483 | 25 | Boston Scientific Corporation ($1,187) |
| 2019 | $47,489 | 55 | Medtronic USA, Inc. ($47,410) |
| 2018 | $123,674 | 143 | Medtronic USA, Inc. ($123,102) |
| 2017 | $72,485 | 111 | Medtronic USA, Inc. ($72,485) |
All Payment Transactions
572 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Gastroenterology | ||||||
| 10/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/10/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/09/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Sports Early Intervention | ||||||
| 08/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.07 | General |
| 08/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Opioid Analgesic | ||||||
| 08/20/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: General - Pain Management_NMD | ||||||
| 07/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: PAIN | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: NEUROSCIENCE | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Gastroenterology | ||||||
| 06/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 4,683 | 12,539 | $7.1M | $1.1M |
| 2022 | 32 | 2,488 | 4,842 | $3.9M | $452,337 |
| 2021 | 24 | 643 | 1,309 | $894,842 | $82,178 |
| 2020 | 17 | 1,469 | 1,983 | $843,026 | $111,808 |
Total Patients
9,283
Total Services
20,673
Medicare Billing
$1.7M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 723 | 3,804 | $1.1M | $458,232 | 40.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 335 | 570 | $327,750 | $110,093 | 33.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 213 | 369 | $212,175 | $88,468 | 41.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 548 | 1,069 | $427,600 | $64,574 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 345 | 545 | $128,075 | $42,995 | 33.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 57 | 64 | $755,000 | $35,351 | 4.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 98 | 118 | $436,600 | $28,299 | 6.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 76 | 111 | $750,000 | $26,305 | 3.5% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 34 | 77 | $693,000 | $25,983 | 3.7% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 181 | 184 | $63,333 | $25,412 | 40.1% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 181 | 184 | $60,849 | $23,852 | 39.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 55 | 61 | $343,400 | $18,186 | 5.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 71 | 93 | $283,800 | $16,886 | 5.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 73 | 107 | $432,360 | $13,576 | 3.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $35,100 | $12,138 | 34.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 57 | $27,075 | $10,347 | 38.2% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 15 | 27 | $175,500 | $9,820 | 5.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 90 | 130 | $67,890 | $8,213 | 12.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 13 | 17 | $130,000 | $7,381 | 5.7% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 181 | 184 | $9,200 | $6,712 | 73.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 21 | 31 | $154,000 | $6,706 | 4.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 45 | 64 | $42,880 | $6,632 | 15.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 86 | 109 | $54,500 | $6,356 | 11.7% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 181 | 184 | $13,793 | $5,406 | 39.2% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 23 | 24 | $62,400 | $5,002 | 8.0% |
About Dr. Stephen Markewich, MD
Dr. Stephen Markewich, MD is a Pain Medicine healthcare provider based in Wasilla, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295959823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Markewich, MD has received a total of $252,515 in payments from pharmaceutical and medical device companies, with $2,037 received in 2024. These payments were reported across 572 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($199,077).
As a Medicare-enrolled provider, Markewich has provided services to 9,283 Medicare beneficiaries, totaling 20,673 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Anesthesiology, Anesthesiology
- Location Wasilla, AK
- Active Since 04/13/2007
- Last Updated 12/17/2024
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1295959823
Products in Payments
- RESTORE (Device) $66,447
- ADAPTIVESTIM (Device) $58,653
- SYNCHROMED (Device) $54,042
- INTELLIS (Device) $48,070
- VECTRIS (Device) $14,141
- AUGMENT INJECTABLE (Device) $1,315
- Intracept (Device) $1,275
- Omnia (Device) $683.38
- GENERAL - PAIN MANAGEMENT (Device) $661.22
- Senza (Device) $564.87
- MYSTIM (Device) $530.87
- KYPHON Balloon Kyphoplasty (Device) $447.12
- SPECTRA WAVEWRITER (Device) $408.13
- UBRELVY (Drug) $400.64
- Superion (Device) $364.79
- NURTEC ODT (Drug) $312.91
- OPTIMIZER (Device) $304.81
- WaveWriter Alpha Prime 16 (Device) $303.88
- RELISTOR (Drug) $267.28
- SUPERION (Device) $242.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.